Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

Delayed Data
As of Dec 08
 -0.17 / -1.19%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 27.00 and a low estimate of 15.50. The median estimate represents a +76.80% increase from the last price of 14.14.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 215.86%
Growthannually 51.20%


Growthquarterly 3.82%
Growthannually 77.94%
Key to the earnings and sales forecast charts.